LYRZO
"LYRZO" is a word mark owned by AbbVie Inc., filed at the USPTO on October 21, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since May 26, 2026
- Filed
- October 21, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99453645
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns LYRZO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
AbbVie Inc.
ABBV · North Chicago, United States
Representative
Maryam Arastu
AbbVie Inc.
What the mark covers
The products and services LYRZO is filed for, grouped by Nice class.
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About LYRZO
Who owns the trademark "LYRZO"?
The USPTO trademark "LYRZO" (application 99453645) is owned by AbbVie Inc.
What is the status of "LYRZO"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull LYRZO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b4a-0581-7438-8f14-eb9e52b95cd4
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b4a-0581-7438-8f14-eb9e52b95cd4",
"object": "trademark",
"mark_text": "LYRZO",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99453645",
"filing_date": "2025-10-21",
"nice_classes": [
5
],
"owners": [
{
"name": "AbbVie Inc.",
"entity_id": "ent_019ebba6-f00c-713a-b3d0-d4a76c24af73"
}
]
}